BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34456927)

  • 1. G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of
    Yi H; Jiang W; Yang F; Li F; Li Y; Zhu W; Li Q; Fakhar SH; Cao Y; Luo L; Zhang W; He Y
    Front Immunol; 2021; 12():719189. PubMed ID: 34456927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase.
    Niikura M; Komatsuya K; Inoue SI; Matsuda R; Asahi H; Inaoka DK; Kita K; Kobayashi F
    Malar J; 2017 Jun; 16(1):247. PubMed ID: 28606087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
    Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
    Malar J; 2015 May; 14():218. PubMed ID: 26017006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
    Safeukui I; Mangou F; Malvy D; Vincendeau P; Mossalayi D; Haumont G; Vatan R; Olliaro P; Millet P
    Biochem Pharmacol; 2004 Nov; 68(10):1903-10. PubMed ID: 15476661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulation.
    Kuehlwein JM; Borsche M; Korir PJ; Risch F; Mueller AK; Hübner MP; Hildner K; Hoerauf A; Dunay IR; Schumak B
    Immunology; 2020 Feb; 159(2):193-204. PubMed ID: 31631339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Plasmodium MIF-CD74 signaling protects against severe malaria.
    Baeza Garcia A; Siu E; Du X; Leng L; Franke-Fayard B; Janse CJ; Howland SW; Rénia L; Lolis E; Bucala R
    FASEB J; 2021 Dec; 35(12):e21997. PubMed ID: 34719814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling of the brain of mice with experimental cerebral malaria.
    Moussa E; Huang H; Ahras M; Lall A; Thezenas ML; Fischer R; Kessler BM; Pain A; Billker O; Casals-Pascual C
    J Proteomics; 2018 May; 180():61-69. PubMed ID: 28602553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
    Blank J; Behrends J; Jacobs T; Schneider BE
    Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
    Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
    Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women.
    Peters AL; Van Noorden CJ
    J Histochem Cytochem; 2009 Nov; 57(11):1003-11. PubMed ID: 19546473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chorismate synthase mediates cerebral malaria pathogenesis by eliciting salicylic acid-dependent autophagy response in parasite.
    Chakrabarti M; Kannan D; Munjal A; Choudhary HH; Mishra S; Singh S
    Biol Open; 2020 Dec; 9(12):. PubMed ID: 33268332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner.
    Hassan A; Wlodarczyk MF; Benamar M; Bassot E; Salvioni A; Kassem S; Berry A; Saoudi A; Blanchard N
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency.
    Cappadoro M; Giribaldi G; O'Brien E; Turrini F; Mannu F; Ulliers D; Simula G; Luzzatto L; Arese P
    Blood; 1998 Oct; 92(7):2527-34. PubMed ID: 9746794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
    Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms.
    Aguiar AC; Figueiredo FJ; Neuenfeldt PD; Katsuragawa TH; Drawanz BB; Cunico W; Sinnis P; Zavala F; Krettli AU
    Malar J; 2017 Mar; 16(1):110. PubMed ID: 28279180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
    Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
    Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria.
    O'Regan N; Gegenbauer K; O'Sullivan JM; Maleki S; Brophy TM; Dalton N; Chion A; Fallon PG; Grau GE; Budde U; Smith OP; Craig AG; Preston RJ; O'Donnell JS
    Blood; 2016 Mar; 127(9):1192-201. PubMed ID: 26511133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
    Schmidt KE; Kuepper JM; Schumak B; Alferink J; Hofmann A; Howland SW; Rénia L; Limmer A; Specht S; Hoerauf A
    PLoS One; 2018; 13(2):e0192717. PubMed ID: 29438386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coenzyme Q10 exhibits anti-inflammatory and immune-modulatory thereby decelerating the occurrence of experimental cerebral malaria.
    Nyariki JN; Kimani NM; Kibet PS; Kinuthia GK; Isaac AO
    Mol Biochem Parasitol; 2023 Sep; 255():111579. PubMed ID: 37385350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
    Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
    Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.